| Primary |
| Product Used For Unknown Indication |
50.2% |
| Diabetes Mellitus |
21.7% |
| Type 2 Diabetes Mellitus |
17.0% |
| Hypertension |
1.5% |
| Urate Nephropathy |
1.2% |
| Hyperlipidaemia |
0.9% |
| Investigation |
0.9% |
| Cardiac Failure Congestive |
0.6% |
| Diabetes |
0.6% |
| Diabetic Neuropathy |
0.6% |
| Erectile Dysfunction |
0.6% |
| Hypothyroidism |
0.6% |
| Rosacea |
0.6% |
| Stent Placement |
0.6% |
| Type Ii Diabetes Mellitus |
0.6% |
| Drug Use |
0.3% |
| Type 2 Diabetes Mellitus |
0.3% |
| Blood Pressure |
0.3% |
| Cardiac Disorder |
0.3% |
| Cardiovascular Event Prophylaxis |
0.3% |
|
| Bladder Cancer |
12.5% |
| Oedema Peripheral |
9.4% |
| Cardiac Failure Congestive |
8.3% |
| Vomiting |
7.3% |
| Weight Increased |
6.3% |
| Bladder Transitional Cell Carcinoma |
5.2% |
| Left Ventricular Hypertrophy |
5.2% |
| Pulmonary Oedema |
5.2% |
| Renal Impairment |
5.2% |
| Cardiac Failure |
4.2% |
| Haematuria |
4.2% |
| Nausea |
3.1% |
| Oedema |
3.1% |
| Osteopenia |
3.1% |
| Pain In Extremity |
3.1% |
| Pericardial Effusion |
3.1% |
| Product Substitution Issue |
3.1% |
| Renal Failure Acute |
3.1% |
| Ureteric Cancer |
3.1% |
| Diarrhoea |
2.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
22.9% |
| Product Used For Unknown Indication |
20.0% |
| Type 2 Diabetes Mellitus |
17.6% |
| Diabetes Mellitus |
10.6% |
| Hypertension |
8.3% |
| Multiple Myeloma |
5.3% |
| Plasma Cell Myeloma |
2.5% |
| Completed Suicide |
1.9% |
| Insulin Resistance |
1.6% |
| Prophylaxis |
1.6% |
| Hiv Infection |
1.5% |
| Angina Pectoris |
1.1% |
| Hyperlipidaemia |
0.8% |
| Metabolic Syndrome |
0.8% |
| Type 1 Diabetes Mellitus |
0.7% |
| High Density Lipoprotein Decreased |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Iron Deficiency |
0.5% |
| Prostate Cancer |
0.5% |
| Bronchiectasis |
0.4% |
|
| Completed Suicide |
12.1% |
| Myalgia |
9.1% |
| Loss Of Consciousness |
7.6% |
| Weight Increased |
6.8% |
| Inflammation |
6.1% |
| Poisoning |
6.1% |
| Hypoglycaemia |
5.3% |
| Renal Failure Acute |
5.3% |
| Bladder Cancer |
4.5% |
| Death |
4.5% |
| Hepatitis |
4.5% |
| Intentional Drug Misuse |
3.8% |
| Plasma Cell Myeloma |
3.8% |
| Cardiac Failure |
3.0% |
| Left Ventricular Hypertrophy |
3.0% |
| Malaise |
3.0% |
| Metastases To Pancreas |
3.0% |
| Spinal Cord Injury Cervical |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Atrial Fibrillation |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.6% |
| Product Used For Unknown Indication |
21.8% |
| Diabetes Mellitus |
14.8% |
| Type 2 Diabetes Mellitus |
8.5% |
| Hypertension |
7.8% |
| Rheumatoid Arthritis |
2.3% |
| Pain |
2.1% |
| Nuclear Magnetic Resonance Imaging |
1.9% |
| Prophylaxis |
1.8% |
| Blood Cholesterol Increased |
1.6% |
| Hyperlipidaemia |
1.5% |
| Blood Cholesterol |
1.4% |
| Depression |
1.4% |
| Diabetes Mellitus Non-insulin-dependent |
1.3% |
| Hypercholesterolaemia |
1.2% |
| Multiple Myeloma |
1.1% |
| Blood Pressure |
1.1% |
| Cardiac Disorder |
1.0% |
| Asthma |
0.9% |
| Atrial Fibrillation |
0.9% |
|
| Vomiting |
13.8% |
| Weight Decreased |
6.4% |
| Hypoglycaemia |
6.1% |
| Renal Tubular Acidosis |
6.1% |
| Blood Glucose Increased |
5.8% |
| Hyperglycaemia |
5.8% |
| Pancreatitis |
5.4% |
| Urinary Tract Infection |
5.4% |
| Flushing |
4.5% |
| Weight Increased |
4.5% |
| Oedema Peripheral |
4.2% |
| Urticaria |
4.2% |
| Renal Impairment |
3.8% |
| Somnolence |
3.8% |
| Androgenetic Alopecia |
3.5% |
| Death |
3.5% |
| Renal Failure Acute |
3.5% |
| Diarrhoea |
3.2% |
| High Density Lipoprotein Decreased |
3.2% |
| Pruritus |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
38.5% |
| Hiv Infection |
23.1% |
| Type 2 Diabetes Mellitus |
15.4% |
| Hypertension |
7.7% |
| Opportunistic Infection Prophylaxis |
7.7% |
| Blood Glucose Increased |
1.9% |
| Diabetes Mellitus |
1.9% |
| Hyperlipidaemia |
1.9% |
| Renal Cancer Metastatic |
1.9% |
|
| Renal Failure Acute |
36.4% |
| Renal Tubular Acidosis |
27.3% |
| Liver Disorder |
18.2% |
| Pyrexia |
9.1% |
| Vomiting |
9.1% |
|
